120 related articles for article (PubMed ID: 12451471)
1. Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liver.
Ozawa S; Hamada M; Murayama N; Nakajima Y; Kaniwa N; Matsumoto Y; Fukuoka M; Sawada J; Ohno Y
Cancer Chemother Pharmacol; 2002 Dec; 50(6):454-8. PubMed ID: 12451471
[TBL] [Abstract][Full Text] [Related]
2. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
[TBL] [Abstract][Full Text] [Related]
3. Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.
Ikeda K; Yoshisue K; Matsushima E; Nagayama S; Kobayashi K; Tyson CA; Chiba K; Kawaguchi Y
Clin Cancer Res; 2000 Nov; 6(11):4409-15. PubMed ID: 11106261
[TBL] [Abstract][Full Text] [Related]
4. Involvement of microsomal cytochrome P450 and cytosolic thymidine phosphorylase in 5-fluorouracil formation from tegafur in human liver.
Komatsu T; Yamazaki H; Shimada N; Nagayama S; Kawaguchi Y; Nakajima M; Yokoi T
Clin Cancer Res; 2001 Mar; 7(3):675-81. PubMed ID: 11297264
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5'-deoxy-5-fluorocytidine formation.
Tabata T; Katoh M; Tokudome S; Hosakawa M; Chiba K; Nakajima M; Yokoi T
Drug Metab Dispos; 2004 Jul; 32(7):762-7. PubMed ID: 15205393
[TBL] [Abstract][Full Text] [Related]
6. Formation pathways of gamma-butyrolactone from the furan ring of tegafur during its conversion to 5-fluorouracil.
Yamamiya I; Yoshisue K; Matsushima E; Nagayama S
Drug Metab Dispos; 2010 Aug; 38(8):1267-76. PubMed ID: 20463005
[TBL] [Abstract][Full Text] [Related]
7. Rat cytochrome p450 1A and 3A enzymes involved in bioactivation of tegafur to 5-fluorouracil and autoinduced by tegafur in liver microsomes.
Yamazaki H; Komatsu T; Takemoto K; Shimada N; Nakajima M; Yokoi T
Drug Metab Dispos; 2001 Jun; 29(6):794-7. PubMed ID: 11353746
[TBL] [Abstract][Full Text] [Related]
8. Association analysis of CYP2A6 genotypes and haplotypes with 5-fluorouracil formation from tegafur in human liver microsomes.
Wang H; Bian T; Liu D; Jin T; Chen Y; Lin A; Chen C
Pharmacogenomics; 2011 Apr; 12(4):481-92. PubMed ID: 21521021
[TBL] [Abstract][Full Text] [Related]
9. Species variation in the enantioselective metabolism of tegafur to 5-fluorouracil among rats, dogs and monkeys.
Yamamiya I; Yoshisue K; Ishii Y; Yamada H; Yoshida K
J Pharm Pharmacol; 2014 Dec; 66(12):1686-97. PubMed ID: 25117829
[TBL] [Abstract][Full Text] [Related]
10. Expression of CYP2A6 in tumor cells augments cellular sensitivity to tegafur.
Murayama N; Sai K; Nakajima Y; Kaniwa N; Ozawa S; Ohno Y; Sawada J
Jpn J Cancer Res; 2001 May; 92(5):524-8. PubMed ID: 11376561
[TBL] [Abstract][Full Text] [Related]
11. Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats.
Konishi H; Yoshimoto T; Morita K; Minouchi T; Sato T; Yamaji A
J Pharm Pharmacol; 2003 Jan; 55(1):143-9. PubMed ID: 12625878
[TBL] [Abstract][Full Text] [Related]
12. A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.
Daigo S; Takahashi Y; Fujieda M; Ariyoshi N; Yamazaki H; Koizumi W; Tanabe S; Saigenji K; Nagayama S; Ikeda K; Nishioka Y; Kamataki T
Pharmacogenetics; 2002 Jun; 12(4):299-306. PubMed ID: 12042667
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P-450-dependent oxidative cleavage of 1-(tetrahydro-2-furanyl)-5-fluorouracil to 5-fluorouracil.
Kawata S; Minami Y; Tarui S; Marunaka T; Okamoto M; Yamano T
Jpn J Pharmacol; 1984 Sep; 36(1):43-9. PubMed ID: 6438379
[TBL] [Abstract][Full Text] [Related]
14. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C
Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148
[TBL] [Abstract][Full Text] [Related]
15. CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1.
Fujita K; Yamamoto W; Endo S; Endo H; Nagashima F; Ichikawa W; Tanaka R; Miya T; Araki K; Kodama K; Sunakawa Y; Narabayashi M; Miwa K; Ando Y; Akiyama Y; Kawara K; Kamataki T; Sasaki Y
Cancer Sci; 2008 May; 99(5):1049-54. PubMed ID: 18380793
[TBL] [Abstract][Full Text] [Related]
16. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
Schüller J; Cassidy J; Dumont E; Roos B; Durston S; Banken L; Utoh M; Mori K; Weidekamm E; Reigner B
Cancer Chemother Pharmacol; 2000; 45(4):291-7. PubMed ID: 10755317
[TBL] [Abstract][Full Text] [Related]
17. Biotransformation of coumarin by rodent and human cytochromes P-450: metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice.
Zhuo X; Gu J; Zhang QY; Spink DC; Kaminsky LS; Ding X
J Pharmacol Exp Ther; 1999 Feb; 288(2):463-71. PubMed ID: 9918546
[TBL] [Abstract][Full Text] [Related]
18. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Supermix as an in vitro model of human liver microsomal drug metabolism.
Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
Biopharm Drug Dispos; 2002 Jul; 23(5):183-90. PubMed ID: 12116049
[TBL] [Abstract][Full Text] [Related]
20. Enantioselectivity in the cytochrome P450-dependent conversion of tegafur to 5-fluorouracil in human liver microsomes.
Yamamiya I; Yoshisue K; Ishii Y; Yamada H; Yoshida K
Pharmacol Res Perspect; 2013 Oct; 1(1):e00009. PubMed ID: 25505563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
